Put down the pipette. A fresh fight just broke out over the future of biology, and the crowd is already picking sides. The question on the table: which GenAI-for-biology approach will actually deliver real-world breakthroughs first?
Out of the gate, "Multimodal wet-lab automation" leads with 66% consensus and 6 holders behind it. That's the robots-in-the-lab camp: machines that see, measure and run experiments, and maybe never ask for a coffee break.
Right behind them is "Foundation-model discovery" at 9% consensus with 8 holders. It's the big-brain AI crowd, betting that giant models trained on biological data will find the next big thing before a robot arm even warms up. Hands versus brains, basically.
Don't count out the rest of the ballot either: 3. Cell-free pipelines, CRISPR tuning and digital twins all have their believers, and a market this new can flip fast.
So far 12 unique traders have put $30,302 behind their opinions, and trading opened less than a day ago. Our take, and it's just a take: the early robot lead could be people backing what they can see, while the model fans are playing a longer game.
These numbers come from live opinion markets on Morfi, where people back their views with real money. Think the crowd has it wrong? Join the market and pick your side before the lab coats settle it.